Anti-Annexin V/ANXA5 antibody [VAA-33] (FITC) ab63556 from Abcam

Product Specs
ItemAnti-Annexin V/ANXA5 antibody [VAA-33] (FITC)
CompanyAbcam
Price Supplier Page View Company Product Page
Catalog Numberab63556
Antibody TypePrimary
ApplicationsFlow Cytometry
CloneVAA-33
Conjugate/TagFITC
HostMouse, Nude mouse
ClonalityMonoclonal
Quantity50 test
IsotypeIgG2a
Concentration0.2 mg/ml
Gene NameANXA5
ReactivityHuman
TargetAnnexin V

Add to Compare List

Abcam

Discovery Drive

Cambridge Biomedical Campus

Cambridge CB2 0AX

United Kingdom

Phone: +44 (0) 1223 696000 (option 1)
+44 (0) 1223 696000 (option 2)
+44 (0) 1223 771600

Company Profile

Website: http://www.abcam.com

(1) Tissue Factor-Enriched Neutrophil Extracellular Traps Promote Immunothrombosis and Disease Progression in Sepsis-Induced Lung InjuryFrontiers in Cellular and Infection MicrobiologyJuly 14, 2021Hao Zhang, Yilu Zhou, Mengdi Qu, Ying Yu, Zhaoyuan Chen, Shuainan Zhu, Kefang Guo, Wankun Chen, Changhong Miao(5′-CTGCTTCCTGGGCTATTTTG-3′). Flow Cytometry Analysis Platelets were stained with anti-annexin/ANXA5 antibody (Abcam, ab63556) and anti-CD62P antibody (Abcam, ab234221). Anti-CD61-PerCP antibody (BD Biosciences, 347407) was chosen

(2) Upregulation of suppressor of cytokine signaling 3 ameliorates spinal degenerative disease in adolescents by mediating leptin and tumor necrosis factor‑α levelsExperimental and Therapeutic MedicineJuly 17, 2019Xiao‑Ming Tang, Jian Dai, Hai‑Lang Sunagainst TNF‑ α (1:20; cat. no. MABF352; Sigma‑Aldrich; Merck KGaA) and FITC‑labeled Annexin V (1:10; cat. no. ab63556; EXPERIMENTAL AND THERAPEUTIC MEDICINE 18: 2231-2237, 2019 Abcam) at 4˚C for 30 min. After cells

(3) MicroRNA‑1271 inhibits cellular proliferation of hepatocellular carcinomaOncology LettersSeptember 25, 2017Andong Qin, Jiehua Zhu, Xingxiang Liu, Dongxiao Zeng, Maolin Gu, Chun Lvalbumin at room temperature for 30 min. Cells were stained with Anti‑Annexin V antibody (1:500, cat. no., ab63556; Abcam) at room temperature for 20 min. Bioinformatics methods. The miR‑1271 targets predicted by algorithms

(4) Chloramidine/Bisindolylmaleimide-I-Mediated Inhibition of Exosome and Microvesicle Release and Enhanced Efficacy of Cancer ChemotherapyInternational Journal of Molecular SciencesMay 9, 2017Uchini S. Kosgodage, Rita P. Trindade, Paul R. Thompson, Jameel M. Inal, Sigrun Lange

(5) Chloride channels are necessary for full platelet phosphatidylserine exposure and procoagulant activityCell death & diseaseDecember 19, 2013Harper MT, Poole AW.

(6) miR-204 targets Bcl-2 expression and enhances responsiveness of gastric cancerCell death & diseaseJanuary 1, 2012A Sacconi, F Biagioni, V Canu, F Mori, A Di Benedetto, L Lorenzon, C Ercolani, S Di Agostino, A M Cambria, S Germoni, G Grasso, R Blandino, V Panebianco, V Ziparo, O Federici, P Muti, S Strano, F Carboni, M Mottolese, M Diodoro, E Pescarmona, A Garofalo, G Blandino

(7) Protein kinase Ctheta negatively regulates store-independent Ca2+ entry and phosphatidylserine exposure downstream of glycoprotein VI in plateletsThe Journal of biological chemistryJune 25, 2010Harper MT, Poole AW.

(8) Creation of a novel peptide with enhanced nuclear localization in prostate and pancreatic cancer cell linesBMC biotechnologyJanuary 1, 2010H Dan Lewis, Ali Husain, Robert J Donnelly, Dimitrios Barlos, Sheraz Riaz, Kalyani Ginjupalli, Adetola Shodeinde, Beverly E Barton

(9) BRCA1 and Tip60 determine the cellular response to ultraviolet irradiation through distinct pathwaysThe Journal of cell biologyJuly 14, 2008Kranz D, Dohmesen C, Dobbelstein M.

Be the First to Write a Review!

Anti-Annexin V/ANXA5 antibody [VAA-33] (FITC) from Abcam

Abcam

Citations (9)

Reviews

Anti-Annexin V/ANXA5 antibody [VAA-33] (FITC) from Abcam

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map